12/12/2008 Telecon - RiaSTAP

 
Memorandum


From:
Laura Wood, OBRR/DH/LH 

To: 
The file of STN 125317/0 and Vasantha Kumar, OBRR/DBA/RPMB 

Company:
CSL Behring GmbH 

Product:
Fibrinogen Concentrate (Human), RiaSTAP™ 

Subject:
Telephone call with David Desris 

Summary

 On December 12, 2008, Mr. Desris called to see when the company would be receiving a communication from CBER regarding the pharmacovigilance and labeling reviews. I told him that we hoped to send something by the end of that week
